Shilpa Medicare has informed that the US FDA intimated the Company that based on its inspection from 11th November to 30th November 2017 the Unit of the Company located at S-20 TO S-24/A, pharmaceutical Formulations SEZ TSIIC, Green Industrial Park, Polepally, Jadcherla, Mahabubnagar, Telangana, India, has been determined that the inspection classification of this facility is VAI.
The above information is a part of company’s filings submitted to BSE.